February 5

Led by Associate Professor Amy Barton Pai, ACPHS is collaborating with Albany Medical Center Hospital to conduct a Phase 1 pharmacokinetic study examining the removal of ceftaroline fosamil (brand name: Teflaro) in critically ill patients receiving continuous renal replacement therapy. Ceftaroline, which is approved for the treatment of community acquired bacterial pneumonia and skin structure infections, has also been shown to be active against drug resistant bacteria such as MRSA. The goal of the study is to define the dosing recommendations for the medication in this population of patients.

Vermont Campus students and faculty members joined professionals from across the state at Pharmacy Legislative Day last Friday in Montpelier. The group met with a number of key legislators including Gov. Peter Shumlin (pictured in back row with yellow tie) and Ron Klein, the new Executive Officer of the Vermont Board of Pharmacy. Students also successfully demonstrated their clinical skills by taking blood pressure and glucose readings for legislators and staffers. 

The team of Melanie Blais, Dan Corwin, and Alison DeGennaro beat out five other teams from the College for the right to represent ACPHS at the National Student Pharmacist Compounding Competition. Like the national competition, the ACPHS competition consisted of a regulatory section, poster presentation, and compounding challenge. The national competition will take place March 21-24 in Gainesville, Florida. 

Junior Casey Redfern became the 19th player in the long history of ACPHS men's basketball to total 1,000 points when he reached the milestone in last Thursday's win vs. Davis College. He leads the Panthers with an average of 21.2 points per game and is third on the team with 6.2 rebounds per game. Redfern's strong season has helped the men's team to a 12-4 record and a #4 ranking in the latest USCAA poll. The women's team is also having an excellent season; they are 13-3 and currently ranked #2 among USCAA schools.